Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
medac GmbH
Servier
St. Jude Children's Research Hospital
Medical College of Wisconsin
Sanofi
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
Sanofi
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Biomea Fusion Inc.
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Amgen
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Institute of Hematology & Blood Diseases Hospital, China
Memorial Sloan Kettering Cancer Center
Chimagen Biosciences, Ltd
Therapeutic Advances in Childhood Leukemia Consortium
Fred Hutchinson Cancer Center
Hoffmann-La Roche
M.D. Anderson Cancer Center
Baptist Health South Florida
Beijing Boren Hospital
Beijing Boren Hospital
Ensoma
Cyclacel Pharmaceuticals, Inc.
Celgene
Institute of Hematology and Blood Transfusion, Czech Republic
Astex Pharmaceuticals, Inc.
Loyola University
Kyowa Kirin Co., Ltd.
Washington University School of Medicine
Fred Hutchinson Cancer Center
Amgen
OHSU Knight Cancer Institute
Therapeutic Advances in Childhood Leukemia Consortium
Daiichi Sankyo
Stanford University
St. Anna Kinderkrebsforschung
New Mexico Cancer Research Alliance
Duke University
M.D. Anderson Cancer Center
Bellicum Pharmaceuticals